NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--July 11, 2006--Xechem International, Inc. (OTC BB:XKEM). Xechem International joins in congratulating its subsidiary, Xechem Pharmaceuticals Nigeria, on the...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--July 5, 2006--Xechem International, Inc. (OTC BB: XKEM). Xechem International announced today that its subsidiary, Xechem Pharmaceuticals Nigeria, has received...
SCDAA Convention in Dallas, in Sept., 2006.
1st Pan African Sickle Cell convention - July 25-28 at the Nicon Abuja Hilton.
Links:
http://www.pennypickers.com/
...
Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF
Xechem International, Inc. (OTC BB: XKEM stock message board) Xechem International announced today that it...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec. 29, 2005--Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today it has received $566,360 from the sale of net operating losses...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec. 20, 2005--Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today that it has settled its antitrust lawsuit against Bristol-Meyers...
#6: XKEM News Xechem Expands its Arsenal for Treating Sickle Cell Disease; Licenses New Anti-Sickling Agent from Virginia Commonwealth University (VCU)
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec. 9, 2005--Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today that it has acquired the exclusive, worldwide licensing rights to...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Oct. 4, 2005--Xechem International, Inc. (OTC BB: XKEM) Xechem International announced today that its wholly owned subsidiary, Xechem UK Ltd., has received...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Aug. 30, 2005--Xechem International, Inc. (OTC BB: XKEM) Xechem International today announced the formation of Xechem UK Ltd., a wholly owned subsidiary based...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--July 11, 2005--Xechem International, Inc. (OTC BB: XKEM) Board of Directors today announced the establishment and charter membership of its Sickle Cell...
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--June 29, 2005--Xechem International, Inc. (OTC BB: XKEM) announced today that it completed the sale of the majority of its interest in CepTor Corporation (OTC...
Xechem Announces Significant Progress in the Development of Its Sickle Cell Disease Drug NICOSAN/ HEMOXIN
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Feb. 17, 2005--Xechem International Inc. (OTCBB:...